Clinical Trials Directory

Trials / Completed

CompletedNCT05289414

Pulsed Radiofrquency Targeting Mid Cervical Medial Branches Versus GON for Cervicogenic Headache

Clinical Efficacy of Pulsed Radiofrequency Treatment Targeting the Mid Cervical Medial Branches Versus Greater Occipital Nerve for Cervicogenic Headache

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
43 (actual)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Accepted

Summary

To detect the Clinical efficacy of pulsed radiofrequency treatment targeting the mid cervical medial branches versus greater occipital nerve for cervicogenic headache

Detailed description

Cervicogenic headache (CHA) is one of the secondary headache disorders. The prevalence of CHA was estimated to be \~4.1%, and most of the patients affected by CHA report un-resolved, recurrent throbbing pain. it has been treated with many treatment modalities, such as the administration of medi-cines, physiotherapy, transcutaneous electrical nerve stimulation, and interventional pro-cedures. However, these treatments do not result in long-term relief for many patients and need to be repeated Pulsed radiofrequency treatment (PRF) is one of the modalities used to treat CHA . CHA has been known to originate from the convergence of the 3 upper cervical and tri-geminal afferents, and therefore, many physicians have performed PRF targeting the upper cervical structures (occipital nerve, C2 dorsal root ganglion). However, this results in only short-term pain relief in the posterior head, and it can lead to some complications, such as vascular and nerve injuries. Because of these limitations, we will attempt PRF targeting the mid-cervical medial branches

Conditions

Interventions

TypeNameDescription
DEVICERadiofrequency on mid cervical medial branchespatients with diagnosis of cervicogenic headache will be subjected to radiofrequency on mid cervical medial branches
DEVICERadiofrequencypatients with diagnosis of cervicogenic headache will be subjected to radiofrequency on Greater occipital nerve

Timeline

Start date
2022-09-01
Primary completion
2024-11-01
Completion
2024-12-31
First posted
2022-03-21
Last updated
2025-03-07

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05289414. Inclusion in this directory is not an endorsement.